In tumor biology, GPER1 has been shown to facilitate cancer progression and migration, serving as a poor prognostic factor in ER-negative and human epidermal growth factor receptor 2 (HER2)-overexpressed breast and lung cancer cell lines [12–14, 19, 31, 32]. This evidence concerns the gene ERBB2 and neoplasm.